Literature DB >> 28685418

Dysfunctional lens syndrome.

Mohammad Reza Sedaghat1, Hamed Momeni-Moghaddam2, Shehzad S Naroo3, Hossein Ghavamsaeedi1, Alireza Vahedi1.   

Abstract

PURPOSE: To report the pre- and post-operative findings of a case with dysfunctional lens syndrome.
METHODS: An adult patient was evaluated using iTrace aberrometer, Tomey topographer and slitlamp biomicroscopy to confirm dysfunctional lens syndrome.
RESULTS: A 45-year-old male patient presented with the chief complaint of poor visual quality; uncorrected visual acuity 20/40 in the right eye, best spectacle corrected visual acuity 20/25 in the right eye with refraction Plano/-1.50 × 80 (SE = -0.75D). Pre- and post-operative root-mean-square (RMS) of total higherorder aberrations in the entire eye, the internal optics and the cornea were 0.350 & 0.257, 0.311 & 0.236 and 0.214 & 0.191 micron (μ), respectively. Also, the magnitude of preoperative total, internal and corneal coma was 0.254 μ × 222°, 0.274μ×242° and 0.097μ × 131° and postoperative values were 0.170 μ × 162°, 0.131 μ × 177°, 0.054 μ × 125°, respectively.
CONCLUSION: These results show that sometime the HOAs of the internal optics, mainly crystalline lens, are not compensated by the cornea and this may cause visual discomfort in the absence of any significant cataract, this situation is known as dysfunctional lens syndrome (DLS).

Entities:  

Keywords:  Crystalline lens; Dysfunctional lens syndrome; Higher-order aberration; Internal aberration

Mesh:

Year:  2017        PMID: 28685418     DOI: 10.1007/s10792-017-0622-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Wave aberrations of the isolated crystalline lens.

Authors:  Austin Roorda; Adrian Glasser
Journal:  J Vis       Date:  2003-04-16       Impact factor: 2.240

2.  Age-related changes in ocular and corneal aberrations.

Authors:  Takashi Fujikado; Teruhito Kuroda; Sayuri Ninomiya; Naoyuki Maeda; Yasuo Tano; Tetsuro Oshika; Yoko Hirohara; Toshifumi Mihashi
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

3.  Changes in ocular monochromatic higher-order aberrations in the aging eye.

Authors:  Douglas A M Lyall; Sathish Srinivasan; Lyle S Gray
Journal:  Optom Vis Sci       Date:  2013-09       Impact factor: 1.973

Review 4.  Wave aberration of human eyes and new descriptors of image optical quality and visual performance.

Authors:  Marco Lombardo; Giuseppe Lombardo
Journal:  J Cataract Refract Surg       Date:  2010-02       Impact factor: 3.351

Review 5.  Applications of wavefront technology.

Authors:  Glauco Reggiani Mello; Karolinne Maia Rocha; Marcony R Santhiago; David Smadja; Ronald R Krueger
Journal:  J Cataract Refract Surg       Date:  2012-09       Impact factor: 3.351

6.  Crystalline lens optical dysfunction through aging.

Authors:  Jorge L Alió; Patricia Schimchak; Herminio P Negri; Robert Montés-Micó
Journal:  Ophthalmology       Date:  2005-09-23       Impact factor: 12.079

7.  Higher-order aberrations of age-related cataract.

Authors:  Karolinne Maia Rocha; Walton Nosé; Kátia Bottós; Juliana Bottós; Lisângela Morimoto; Eduardo Soriano
Journal:  J Cataract Refract Surg       Date:  2007-08       Impact factor: 3.351

  7 in total
  3 in total

1.  Characterization of Dysfunctional Lens Index and Opacity Grade in a Healthy Population.

Authors:  Elena Martínez-Plaza; Pedro Ruiz-Fortes; Roberto Soto-Negro; Carlos J Hernández-Rodríguez; Ainhoa Molina-Martín; Alfonso Arias-Puente; David P Piñero
Journal:  Diagnostics (Basel)       Date:  2022-05-07

Review 2.  From Presbyopia to Cataracts: A Critical Review on Dysfunctional Lens Syndrome.

Authors:  Joaquín Fernández; Manuel Rodríguez-Vallejo; Javier Martínez; Ana Tauste; David P Piñero
Journal:  J Ophthalmol       Date:  2018-06-27       Impact factor: 1.909

3.  Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome.

Authors:  Alfredo Holgueras; Manuel Marcos; Elena Martínez-Plaza; Alberto López-Miguel; Alberto Mansilla; Miguel J Maldonado
Journal:  Ophthalmol Ther       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.